The research team designed an innovative diagnostic kit by utilizing the principle of water and oil layering to detect ...
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
The FDA has approved the first at-home, nonprescription test for chlamydia, gonorrhea, and trichomoniasis in women. The Visby ...
Reacta Healthcare is in the process of seeking market authorization for its kits as diagnostic products for use beyond the clinical research arena. “In the next 2 years, we aim to gain approval ...
Agilent Technologies recently achieved EU IVDR approval for two new indications of its PD-L1 IHC 28-8 pharmDx kit, expanding treatment options for early-stage NSCLC and advanced melanoma.